Monographie - Hydrochlorothiazide - Stabilis 4.0

Последно актуализиране :
08/05/2024

Диуретик

Hydrochlorothiazide

Орален разтвор

Стабилност на лекарствени препарати

Стабилност на смеси

Фактори, повлияващи стабилността

Съвместимост

Библиография

Pdf

Химична структура

Орален разтвор

Библиография

Орален разтвор

Библиография : Hydrochlorothiazide

	Вид	Публикация
2435	Списание	Allen LV, Jr, Erickson MA, Stability of labetalol hydrochloride, metoprolol tartrate, verapamil hydrochloride, and spironolactone with hydrochlorothiazide in extemporaneously compounded oral liquids Am J Health-Syst Pharm 1996 ; 53: 2304-2309.
3361	Списание	Santovena A, Hernandez-Paiz Z, Farina J.B. Design of a pediatric oral formulation with a low proportion of hydrochlorothiazide. Int J Pharm 2012 ; 423: 360-364.
3399	Плакат	Li Y.Y, Postma D.J, Wagenaar H.W.G. Development of a hydrochlorothiazide 0.5 mg/mL oral solution for children. EAHP Congress Paris 2013
3910	Списание	Polonini H.C, Silva S .L, de Almeida T.R, Brand?o M.A, Ferreira A.O. Compatibility of caffeine, carvedilol, clomipramine hydrochloride, folic acid, hydrochlorothiazide, loperamide hydrochloride, methotrexate, nadolol, naltrexone hydrochloride and pentoxifylline in SyrSpend SF PH4 oral suspensions. EJHP 2016 ; 23: 352-358.
4177	Списание	Polonini H, Loures da Silva S, Fernandes Brandao M.A, Bauters T, De Moerloose B, De Oliveira Ferreira A. Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF PH4. Int J Pharm Compound 2018 ;22,6:516-526
4198	Списание	Uriel M, Gomez-Rincon C, Marro D. Stability of regularly prescribed oral liquids formulated with SyrSpend® SF. Pharmazie 2018 73;196-201
4256	Списание	Binson G, Beuzit K, Migeot V, Marco L, Troussier B, Venisse N, Dupuis A. Preparation and Physicochemical Stability of Liquid Oral Dosage Forms Free of Potentially Harmful Excipient Designed for Pediatric Patients. Pharmaceutics 2019 ;11,190:

Mentions Légales